Skip to main content

Happy New Year, Affluenza Sufferers

U.S. Marshals Offering Bounty On Ethan Couch, Missing ‘Affluenza’ Teen

As the old year crawled to an end, we all received a respite from boring campaign news by a reprise of the "affluenza" story.

To review: lawyers for Ethan Couch maintain that his parents spoiled him so thoroughly that he cannot tell right from wrong, that is, he is insane. They lost on that point, and he was convicted of drunk driving that resulted in the death of four people. BUT the sentencing judge seems to have concluded that there was a mitigating factor there, because he suspended the sentence of imprisonment. Maybe the judge simply wanted to reward the creation of a clever portmanteau.

Anyway, Couch never spent a day in lock up over those four deaths, although as a convicted felon he was required to check in regularly with his probation officer, and to give up alcohol.

Apparently, upon the surfacing of a video suggesting that he was violating the latter condition, he violated the former. He has disappeared.

So, in two sentences:

1) Couch was thought to have been a victim of moral spoilage because he had been coddled through his life so,
2) the legal system became complicit in the continued coddling.

The remarkable thing about the Couch case is that everybody seems to be on the same side. I haven' yet encountered anyone who defends the "affluenza" legal argument. BUT....

People still see it through their own ideological glasses:

if you are of the left, you'll see Couch as the beneficiary of white man/upper class privilege;
If you are of the right, you'll see the case as one of moral decay brought on by relativism, a permissive culture, etc.

And of course if you're an anarchist, you might make the observation that punishing the Couch's of the world, and deterring future Couch's, is one of the few core functions of the State  that almost every non-anarchist agrees on, that is, that this is a dramatic failure at the core of the myth of sovereignty.

 


Comments

  1. Christopher,

    I don't understand the anarchist position. Couch was punished, if minimally, and we do not know whether the punishment was sufficient to have deterred him or others from driving while drunk. But let's assume for the sake of argument that the punishment was a dramatic failure as a deterrent. How was it, however, a dramatic failure at the core of the myth of sovereignty? What does it have to do with whether sovereignty is a myth?

    You don't mention that, in the United States, the problem for most people who are convicted of a crime is the opposite of what happened to Couch; for most people, punishments are far too harsh. Does that too show a dramatic failure at the core of the myth of sovereignty? If so, how so?

    Happy New Year!

    ReplyDelete
  2. The "core" language I used refers to the regular "minimalist" argument. People often say, "I'm against government, except as a small nightwatchman. We need the state for that." So the Couch case sheds dramatic light on the core role of the state, the role that people who have become mostly discontented with leading ideas about legitimacy are least willing to shed.

    Yes, I agree that an excess of punishment is a more common failing that a paucity. I'm reminded of Aristotle's idea of a "golden mean." Every activity requiring virtue can go wrong in either of two ways.

    The less common of those two ways, the glaring error through leniency in situations requiring justice, is the more dramatic challenge though. If we're going to keep a state around specifically because we think we need a nightwatchman, we may just respond to a nightwatchman who dozes away on his watch with a shrug of the shoulders and a final abandonment of the idea.

    ReplyDelete

Post a Comment

Popular posts from this blog

A Story About Coleridge

This is a quote from a memoir by Dorothy Wordsworth, reflecting on a trip she took with two famous poets, her brother, William Wordsworth, and their similarly gifted companion, Samuel Taylor Coleridge.



We sat upon a bench, placed for the sake of one of these views, whence we looked down upon the waterfall, and over the open country ... A lady and gentleman, more expeditious tourists than ourselves, came to the spot; they left us at the seat, and we found them again at another station above the Falls. Coleridge, who is always good-natured enough to enter into conversation with anybody whom he meets in his way, began to talk with the gentleman, who observed that it was a majestic waterfall. Coleridge was delighted with the accuracy of the epithet, particularly as he had been settling in his own mind the precise meaning of the words grand, majestic, sublime, etc., and had discussed the subject with William at some length the day before. “Yes, sir,” says Coleridge, “it is a majestic wate…

Hume's Cutlery

David Hume is renowned for two pieces of cutlery, the guillotine and the fork.

Hume's guillotine is the sharp cut he makes between "is" statements and "ought" statements, to make the point that the former never ground the latter.

His "fork" is the division between what later came to be called "analytic" and "synthetic" statements, with the ominous observation that any books containing statements that cannot be assigned to one or the other prong should be burnt.

Actually, I should acknowledge that there is some dispute as to how well or poorly the dichotomy Hume outlines really maps onto the analytic/synthetic dichotomy. Some writers maintain that Hume meant something quite different and has been hijacked. Personally, I've never seen the alleged difference however hard they've worked to point it out to me.

The guillotine makes for a more dramatic graphic than a mere fork, hence the bit of clip art above.

I'm curious whe…

Cancer Breakthrough

Hopeful news in recent days about an old and dear desideratum: a cure for cancer. Or at least for a cancer, and a nasty one at that.

The news comes about because investors in GlaxoSmithKline are greedy for profits, and has already inspired a bit of deregulation to boot. 

The FDA has paved the road for a speedy review of a new BCMA drug for multiple myeloma, essentially cancer of the bone marrow. This means that the US govt has removed some of the hurdles that would otherwise (by decision of the same govt) face a company trying to proceed with these trials expeditiously. 

This has been done because the Phase I clinical trial results have been very promising. The report I've seen indicates that details of these results will be shared with the world on Dec. 11 at the annual meeting of the American Society of Hematology. 

The European Medicines Agency has also given priority treatment to the drug in question. 

GSK's website identifies the drug at issue as "GSK2857916," althou…